Clinical Trials Browser

Phase 1/2 × Neoplasms × Clinical Trials, Phase II as Topic × Clear all

NCT05958121 2025-11-18

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

Phase 1/2 Recruiting

Neoplasms, Recurrence

NCT04503265 2025-05-01

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Phase 1/2 Recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Disease Progression